11 results
8-K
EX-99.1
COYA
Coya Therapeutics Inc
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
partnership with Dr. Reddy’s, a world class organization that defines excellence in innovation and commercialization. While the agreement provides
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
or technical innovation, or if its authorization would be in the interest of public health in the EEA. Under the centralized procedure the maximum … product is expected to be of a major public health interest, particularly from the point of view of therapeutic innovation. The timeframe for the evaluation
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
in, and conduct comparative clinical effectiveness research, along with funding for such research;
establishment of a Center for Medicare Innovation … substance not yet authorized in the EEA, is a significant therapeutic, scientific or technical
innovation, or if its authorization would
S-1/A
vsmdh7hxnzo o7j
5 Dec 22
IPO registration (amended)
8:16am
S-1
xiqwicsa
18 Nov 22
IPO registration
5:06pm
DRS/A
kt3z5c2h
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
egow1th kydsnl
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
op7ail6as74m0sc
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next